One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
The key role of thrombosis: focus on acute coronary syndrome, venous thrombo-embolism, and atrial fibrillation
Filippo Crea
doi : 10.1093/eurheartj/ehad835
Volume 45, Issue 1, 1 January 2024
When technology innovation is the only path to treat patients in economic crisis countries: the Syrian experience
Amr Abdin 1,2*, Asim Katbeh1, and Yassin Bani Marjeh
The first European Union approval of a new medicine to treat cardiovascular diseases in 2023: why is it important to collaborate with the European Medicines Agency?
Piotr Szyma?ski 1*, Eva Irene Bossano Prescott 2, and Franz Weidinger
The evolution of transcatheter valvular interventions: current evidence
Rasha Kaddoura 1* and Mohammed Al-Hijji
Does MULTISTARS shed light on the timing of complete revascularization in ST-elevation myocardial infarction?
Daniela Pedicino 1* and Giovanna Liuzzo1
Platelet biology and function: plaque erosion vs. rupture
Constance C.F.M.J. Baaten 1,2, Magdolna Nagy 1, Wolfgang Bergmeier 3,4, Henri M.H. Spronk 1,5,6, and Paola E.J. van der Meijden
Artificial intelligence in detecting left atrial appendage thrombus by transthoracic echocardiography and clinical features: the Left Atrial Thrombus on Transoesophageal Echocardiography (LATTEE) registry
Konrad Pieszko 1,2,3, Jaros?aw Hiczkiewicz2,3, Katarzyna ?ojewska3, Beata Uzi?b?o-?yczkowska 1,4, Pawe? Krzesi?ski 1,4, Monika Gawa?ko 1,5,6,7, Monika Budnik 1,5, Katarzyna Starzyk 8, Beata Wo?akowska-Kap?on8, Ludmi?a Dani?owicz-Szymanowicz 9, Damian Kaufmann 9, Maciej W?jcik 10, Robert B?aszczyk 10, Katarzyna Mizia-Stec 11, Maciej Wybraniec 11, Katarzyna Kosmalska 12, Marcin Fija?kowski13, Anna Szyma?ska14, Miros?aw D?u?niewski14, Micha? Kucio15, Maciej Haberka 15, Karolina Kupczy?ska 16, B?a?ej Michalski16, Anna Tomaszuk-Kazberuk17, Katarzyna Wilk-?ledziewska17, Renata Wachnicka-Truty18, Marek Kozi?ski 1,18, Jacek Kwieci?ski19, Rafa? Wolny19, Ewa Kowalik 20, Iga Kolasa2, Agnieszka Jurek1,4, Jan Budzianowski 1,2,3, Pawe? Burchardt 1,21, Agnieszka Kap?on-Cie?licka 1,5†, and Piotr J. Slomka
Artificial intelligence and innovation of clinical care: the need for evidence in the real world
Andrew J. Fletcher 1,2, Casey L. Johnson 1, and Paul Leeson
The Vienna Prediction Model for identifying patients at low risk of recurrent venous thromboembolism: a prospective cohort study
Paul A. Kyrle 1,2, Lisbeth Eischer1, Hana ?inkovec3, Paul Gressenberger4, Thomas Gary4, Marianne Brodmann4, Georg Heinze 3, and Sabine Eichinger 1,
The science and art of predicting recurrent VTE
Marc Carrier 1 and Peter Verhamme
Stroke and bleeding risk in atrial fibrillation with CHA2DS2-VASC risk score of one: the Norwegian AFNOR study
Mariam Anjum 1,2*, Inger Ariansen 2, Vidar Hjellvik2, Randi Selmer2, Lars J. Kjerpeseth2, Eva Skovlund3, Marius Myrstad1,4, Hanne Ellekj?r5,6, Ingrid E. Christophersen1,7, Arnljot Tveit 1,8, and Trygve Berge
Anticoagulation for atrial fibrillation in patients with intermediate stroke risk: is the grey zone becoming less grey?
Francis E. Marchlinski *, Alireza Oraii , and Daniele Muser
What is the optimal duration of dual antiplatelet therapy after percutaneous coronary intervention in high-bleeding risk: 1 month or 3 months?
Yuqin Zhao * and Yafang Chen
One or 3 months dual antiplatelet therapy in high bleeding risk patients: splitting hair or aiming at the bullseye?
Francesco Costa 1*, Claudio Montalto2, and Marco Valgimigli
Intracardiac pseudophallus
Francisco B. Alexandrino1, Kevin L. Greason 2, and Ratnasari Padang
A fish bone wandering in the body
Yiyuan Li , Qiang Guo , and Bin Huang
Correction to: 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC
Correction to: 2023 ESC Guidelines for the management of endocarditis: Developed by the task force on the management of endocarditis of the European Society of Cardiology (ESC) Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS) and the European Association of Nuclear Medicine (EANM)
